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Abstract Thermodynamic analysis of spermine binding to
mitochondria treated with ruthenium red and deenergized with
either FCCP or antimycin A confirms the presence of two
polyamine binding sites, S1 and S2, both with monocoordination,
as previously observed in energized mitochondria [Dalla Via et
al., Biochim. Biophys. Acta 1284 (1996) 247^252]. Both sites
undergo a marked change in binding capacity and binding
affinity upon mitochondrial deenergization. This change is most
likely responsible for the incomplete or delayed spermine-
mediated inhibition of the permeability transition induced in
deenergized mitochondria.
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1. Introduction
Overloading of the mitochondrial matrix with Ca2, in
combination with any of a wide variety of inducing agents,
promotes a permeability transition of the inner mitochondrial
membrane that results in a dramatic increase in permeability
to molecules and ions up to 1500 Da in size. The ¢nal
consequence of this process is the collapse of the proton elec-
trochemical gradient paralleled by a shutdown of ATP
synthesis and loss of control of matrix volume (for reviews
see [1,2]).
The discovery that submicromolar concentrations of the
immunosuppressant undecapeptide cyclosporin A (CsA) to-
tally block this process [3,4] would be consistent with the
operation of a proteinaceous pore, and suggests that it re£ects
the transformation of an ion-selective channel or the adenine
nucleotide antiport to a non-speci¢c pore [5,6] or the opening
of a latent high resistance channel [7,8]. It has been proposed
that outer membrane porin [9,10] or a complex of this protein
with hexokinase and creatine kinase [11] might constitute the
pore. The target of CsA seems to be a matrix cyclophilin [12],
a member of the cyclophilin family of peptidyl-prolyl-cis-
trans-isomerases. Notwithstanding the large number of papers
published in the past decade, at present the molecular basis of
the genesis of this process is not understood. Upon Ca2
accumulation, the permeability transition can also be gener-
ated by substituting the classical inducer with an inhibitor of
the Ca2 uniporter such as ruthenium red plus an uncoupler
[8,13,14]. Although the activity of ruthenium red as an inhib-
itor of reverse Ca2 uniport remains controversial [13,15^17],
it has been proposed that the following events are necessary to
trigger the permeability transition: membrane depolarization
[18], reverse Ca2 uniport inhibition [19], prevention of matrix
pH acidi¢cation [8] and binding of external divalent cations to
a speci¢c site [14].
Recently it has been demonstrated that the permeability
transition promotes a loss of endogenous polyamines [20].
The presence of these polycations in the matrix space should
be considered relevant and would be analogous to the activity
of Mg2 and adenine nucleotides in maintaining the energy
barrier of liver mitochondria. Spermine prevents the perme-
ability transition in energized liver [21^26] and heart mito-
chondria [23,27,28] upon induction by Ca2 loading followed
by addition of an inducer such as inorganic phosphate, tert-
butyl-hydroperoxide, phenylarsine oxide, carboxyatractyloside
or palmitoyl CoA. The sensitivity of the permeability transi-
tion of liver mitochondria to spermine depends on the ionic
composition of the incubation medium [23]. Furthermore,
spermine is also able to inhibit the permeability transition in
liver mitochondria when the phenomenon is induced by ruthe-
nium red plus FCCP [23]. The protective action of spermine
resembles that of Mg2 [29] but is much more e¡ective be-
cause of its higher net positive charge [26]. The inhibitory
mechanism of spermine is not known. It has been suggested
that it might act by increasing the a⁄nity of ADP for its
inhibitory binding site [25]. Alternatively, the e¡ect might be
due to the binding of this polycation to an external site with a
consequent change in the membrane surface potential [14].
Spermine-mediated inhibition of pore opening is usually
achieved in energized mitochondria in which the polyamine
is actively transported into the matrix space by a speci¢c
electrophoretic uniport [30,31]. However, the fact that sper-
mine also protects against the permeability transition in dee-
nergized mitochondria [23], in which spermine transport is
almost completely inhibited [32], and the observation that
K interacts with a site outside the mitochondria to decrease
spermine e⁄cacy [23] strongly suggest that an external site is
involved in this action.
By using a new thermodynamic treatment of ligand-recep-
tor interactions [33], it has recently been demonstrated that
two spermine binding sites are present in energized mitochon-
dria [34]. The aim of the present study was to investigate
whether the binding parameters and functional properties of
the spermine binding sites are a¡ected in mitochondria per-
meabilized by the concerted action of ruthenium red plus
either FCCP or antimycin A.
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2. Materials and methods
Rat liver mitochondria were isolated in 0.25 M sucrose and 5 mM
HEPES (pH 7.4) by conventional di¡erential centrifugation.
Protein concentration was assayed by the biuret reaction with bo-
vine serum albumin as a standard.
All incubations were conducted at 20‡C with 1 mg of mitochondrial
protein/ml in a low ionic strength medium, condition used in previous
permeability transition [8,20,24,26], spermine binding [34] and sper-
mine transport [30^32] studies. The medium contained 200 mM su-
crose, 10 mM HEPES (pH 7.4), 5 mM sodium succinate, 1.25 WM
rotenone and 1 mM sodium phosphate. In all experiments 100 WM
CaCl2 was present. Modi¢cations of the standard medium are indi-
cated in the ¢gure legends.
Crude ruthenium red was purchased from Sigma and used without
puri¢cation as previously suggested [35].
Mitochondrial swelling was monitored by apparent absorbance
measurements at 540 nm in a Kontron Uvikon-922 spectrophotome-
ter equipped with a magnetic stirrer and thermostatic control.
Uptake of [14C]spermine was determined by a centrifugal ¢ltration
method as previously described [30,32].
Binding parameters were calculated as previously reported for ener-
gized mitochondria [34] by applying a new thermodynamic treatment
of ligand-receptor interactions [33]. Scatchard and Hill analyses were
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represents the appropriate measure of the extent of multiple coordi-
nation on the i-th site. Bmax;iis the maximum concentration of i-th
sites that may be bound by the ligand, Bi is the concentration of i-th
sites bound by the ligand, Bmax is the maximum receptor-bonded
ligand concentration, and B is the receptor-bonded ligand concen-
tration. F  is the free ligand concentration, Ki;jt is the a⁄nity con-
stant of the ligand for the i-th site, j is the occupancy number and t is
time.
Fitting was performed using a FORTRAN program developed in
our laboratory as described in [33].
The distribution of total bound spermine on its respective binding
sites was calculated by parameter Xi(F) obtained by means of equa-
tion 3:
XiF  Bmax;i3BiBmax3B 
1
1 Li F 
3
where the quantity is a parameter that describes the in£uence of the
parallel ¢lling of the other k-th sites in comparison to ¢lling of the i-th
site [33].
3. Results
The results reported in Fig. 1 show that treatment of respir-
ing mitochondria in a standard sucrose-containing medium
with ruthenium red followed by FCCP (panel A) or antimycin
A (panel B) produces an apparent decrease in absorbance at
540 nm (traces a in both panels). This change in absorbance is
indicative of mitochondrial swelling accompanying the di¡u-
sion of sucrose towards the matrix, typical of pore opening. If
ruthenium red is omitted no absorbance change takes place
(traces b in both panels). As previously reported [23], addition
of 100 WM spermine after ruthenium red and before FCCP
(trace c in panel A) induces an inhibitory e¡ect (90%) that is
the maximum observed; in fact, a higher concentration (trace
d in panel A) does not enhance the inhibition. In this latter
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Fig. 1. E¡ect of spermine on the permeability transition induced by ruthenium red plus FCCP (panel A) or ruthenium red plus antimycin A
(panel B). Rat liver mitochondria (RLM) were incubated in standard medium under the conditions described in Section 2. FCCP (0.2 WM) or
antimycin A (AA, 45 nM) was added as indicated (traces a^d of the respective panels). Spermine (Spm) was added to a ¢nal concentration of
100 WM (traces c) or 250 WM (traces d). Ruthenium red (RR, 1 WM) was present in traces a, c and d of both panels. The inset shows the e¡ect
of 50 WM spermine (trace b) on the permeability transition induced by 100 WM Ca2 plus 3 mM phosphate (trace a). These experiments were
performed 10 times with identical results.
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case no decrease in the initial absorption of the suspension,
which would indicate mitochondrial aggregation, was ob-
served. Mitochondria undergo a similar swelling upon substi-
tution of FCCP with antimycin A (trace a in panel B). Addi-
tion of 100 WM spermine also induces the maximum inhibitory
e¡ect on the absorbance decrease in the presence of antimycin
A (trace c in panel B), but to a lesser extent (80%) compared
to previous experiments performed using FCCP (compare this
trace with trace c in panel A). This di¡erence in the extent of
inhibition in the presence of the two agents is also observed if
spermine is added to the reaction mixture prior to mitochon-
dria (results not reported). Using these mitochondrial prepa-
rations, the permeability transition can also be achieved in the
usual way by incubating mitochondria with 100 WM Ca2 plus
3 mM phosphate, without ruthenium plus FCCP or antimycin
A (see inset in Fig. 1, trace a). In this case, as previously
reported [26], 50 WM spermine is su⁄cient to completely block
matrix swelling (inset in Fig. 1, trace b). The same maximum
extent of inhibition of swelling exhibited by 100 WM spermine
(90% with FCCP and 80% with antimycin A) has also been
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Fig. 2. Concentration-dependent spermine uptake by mitochondria deenergized by FCCP (panels A and C) or antimycin A (panels B and D).
RLM were incubated in standard medium as described in Section 2. The zero time reported in the plot of panels A and B corresponds to
the addition time of di¡erent [14C]spermine concentrations [S] in the range of 5^3000 WM (0.05 WCi/ml) as indicated along the curves. These ad-
ditions were made together with 0.2 WM FCCP (panel A) or 45 nM antimycin A (panel B). Ruthenium red (1 WM) was added in all the
experiments 90 s after RLM and 30 s before the addition of spermine and deenergizer. Open circles report the amount of spermine that binds
instantaneously at zero time. The results represent the mean value of 10 experiments. Panels C and D report zero-time spermine binding
as the function of total spermine concentration. The curves were drawn using zero-time bound spermine values [B] calculated by extrapola-
tion of data from the experiments shown in panels A and B. Total spermine concentrations [S] are the same as those reported in panels A
and B.
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observed by evaluating two other events associated with per-
meability transition induction, i.e. Mg2 e¥ux and sucrose
uptake (data not shown).
Fig. 2 shows the uptake of spermine by mitochondria in-
cubated in standard medium in the presence of ruthenium red
and deenergized with either FCCP (panel A) or antimycin A
(panel B). Twelve spermine concentrations, ranging from 5 to
3000 WM, were tested. In this experiment, after an initial rapid
binding, a very modest uptake of the polyamine is observed
under both deenergizing conditions; this uptake takes place
only during the ¢rst 5 min of the reaction. The rate of uptake
depends on both the spermine concentration and the deener-
gizing agent used and is considerably higher in the presence of
antimycin A (panel B). The di¡erent aliquots of spermine that
bind to the mitochondrial membrane at zero time are calcu-
lated by extrapolation on the y-axis (see dotted line segments
and open circles). Details of the experimental approach used
to measure spermine uptake at zero time are provided in [34].
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Fig. 3. Spermine binding analysis in the presence of FCCP (panel A) or antimycin A (panel B), with the thermodynamic treatment of Scatch-
ard. The insets report the corresponding analysis with the treatment of Hill. The experimental data (open circles) were calculated as follows:
bound spermine values B were as reported in Fig. 2; free spermine concentration F was calculated by subtracting bound spermine B from total
spermine concentration [S] as reported in Fig. 2. The continuous lines represent the theoretical best ¢tting curves whose corresponding equa-
tions are derived from general Eq. 1) for Scatchard analysis and Eq. 2 for Hill analysis (see Section 2 and [33,34]).
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aStandard deviations in the least signi¢cant digits are given in parentheses.





where (No) is the experimental value and (Nc) is the calculated value. For a Scatchard plot, N is given by B/F and for a Hill plot by ln[B/(Bmax3B)].
cData reported from [34].
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The amount of spermine bound at zero time, B, is plotted as
the function of total spermine concentration [S], generating
the diagrams B/S reported in panel C (FCCP-treated) and
panel D (antimycin A-treated).
Fig. 3 shows spermine binding analyses obtained by using
the thermodynamic treatments of Scatchard and Hill [33] as
previously reported for energized mitochondria [34]. Binding
data, plotted as dependence of B/F on B and ln [B/(Bmax3B)
on ln F, are simulated with two series of curve pro¢les belong-
ing to Eqs. 1 and 2, obtained by computer simulations for
several parameters S and ni (see Section 2). The theoretical
curves that satisfactorily ¢t the experimental binding data
obtained in the presence of FCCP (panel A) or antimycin A
(panel B) are typical for two binding sites, S1 and S2, both
with monocoordination.
Table 1 reports spermine binding parameters of deenergized
mitochondria obtained by using both the Scatchard and the
Hill data representation methods. For purposes of compari-
son this table also reports the same parameters previously
determined for energized mitochondria (see [34]). This analy-
sis demonstrates the presence of two monocoordinated bind-
ing sites on the membranes of deenergized mitochondria, as
found in energized mitochondria [34]. The total binding ca-
pacity in the presence of FCCP is 30.32 nmol/mg protein, with
10% and 90% distributed between the S1 and S2 sites respec-
tively. The dissociation constants K1;1 and K2;1 of sites S1 and
S2, respectively, demonstrate that the a⁄nity of S1 is about
22.5 times higher than that of S2. The total spermine binding
capacity in the presence of antimycin A is 25.66 nmol/mg
protein, with 9% and 91% distributed between the S1 and S2
sites, respectively. The dissociation constants K1;1 and K2;1
demonstrate that S2 has a higher a⁄nity than S1, i.e. opposite
to the a⁄nities measured in the presence of FCCP. The main
di¡erence arising from the comparison of binding parameters
reported in Table 1 is that under deenergization conditions
spermine is largely bound to the S2 site. Furthermore, the
dissociation constants undergo di¡erent variations depending
on the deenergizing agent. With FCCP, the spermine binding
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Fig. 4. Molar fraction ratio of spermine binding to mitochondria deenergized by FCCP (panel A) or antimycin A (panel B). The calculations
refer to the amount of spermine required to ¢ll the binding sites. X1(F) and X2(F) are the molar fraction ratios required to ¢ll the ¢rst (S1)
and the second (S2) spermine binding site, respectively. The insets report the subdivision of total bound spermine between the S1 and S2 sites.
The two aliquots, B1 and B2, bound to S1 and S2 sites respectively, were determined by Eq. 3, using the molar fraction ratio X1(F) and X2(F)
of zero-time bound spermine and Bmax1 and Bmax2 values reported in Table 1. An example of this calculation is reported in Fig. 3 of [34].
Table 2





+FCCP 100 WM SPM 4 2.6 1.4
250 WM SPM 5.35 2.97 2.38
+Antimycin A 100 WM SPM 2.8 2.1 0.7
250 WM SPM 4.0 2.35 1.65
Total bound spermine values were calculated from the data as in Fig.
2. The distribution between S1 and S2 sites was calculated by means of
the molar fraction ratio of spermine binding, reported in Fig. 4.
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a⁄nity diminishes at both sites by about two-fold. With anti-
mycin A, the binding a⁄nity decreases at S1 and increases at
S2 by about 2- and 50-fold, respectively. Parameter L1, which
describes the possible in£uence of the parallel ¢lling of S2 on
¢lling of S1, is determined by Eq. 3 (see Section 2) and does
not exhibit any di¡erence between deenergized and energized
mitochondria.
Fig. 4 shows the molar fraction ratios X1(F) and X2(F) for
the aliquot of free spermine that can bind to sites S1 and S2,
respectively, determined in the presence of FCCP (panel A) or
antimycin A (panel B). The values are obtained by using pa-
rameter L1 reported in Table 1. As previously observed for
energized mitochondria [34], these calculations show that with
increasing amounts of bound spermine, X1(F) decreases in the
presence of both deenergizing agents and, conversely, X2(F)
increases. This signi¢es that the S1 site is ¢lled before the S2
site. However, as demonstrated in the insets of Fig. 4, the S2
site begins to bind spermine before the S1 site is ¢lled; this
result was not observed in previous experiments [34].
Table 2 reports the distribution of membrane-bound sper-
mine on sites S1 and S2 in the presence of either FCCP or
antimycin A, measured using two polyamine concentrations
(100 or 250 WM). The table emphasizes that the values of the
S1 site are at saturation at 250 WM spermine.
4. Discussion
The results of the present study demonstrate that besides
protecting against the permeability transition induced in liver
mitochondria by ruthenium red plus FCCP [23] (Fig. 1, panel
A), spermine is also able to inhibit the phenomenon when it is
induced by ruthenium red plus antimycin A (Fig. 1, panel B).
The polyamine is considerably more e¡ective in inhibiting the
permeability transition when the phenomenon is induced by
ruthenium red plus FCCP (compare the two panels in Fig. 1).
Furthermore, the data reported here point out that both
deenergizing agents decrease the capacity of spermine to in-
hibit the permeability transition. In fact, by comparing the
e¡ect of spermine on the swelling of deenergized mitochondria
(panels A and B in Fig. 1) and initially energized mitochon-
dria (inset in Fig. 1), it is evident that the polyamine is fully
inhibitory only in the latter case.
The results reported in Fig. 2, panels A and B, show that
under the conditions in which spermine strongly inhibits the
permeability transition, only a small proportion of the poly-
amine is taken up by deenergized mitochondria. The e¡ect is
slightly more pronounced in the presence of antimycin A
(panel B). This fact could be ascribed to either an imperfect
or delayed pore closure due to the presence of the deenergiz-
ing agents, which permits a low level of polyamine uptake.
Very probably the latter proposal is more plausible, as after
7 min of incubation, no polyamine uptake is yet observable
(data not shown).
Another di¡erence between the mitochondria-spermine in-
teractions in the presence of the two deenergizing agents is
emphasized by comparing panels C and D of Fig. 2. The B/S
diagrams show that zero time spermine binding is consider-
ably higher with FCCP than with antimycin A, yielding no-
ticeably di¡erent curve shapes. These results demonstrate that
the deenergizing agents act on mitochondrial spermine bind-
ing via di¡erent mechanisms.
By using a new thermodynamic treatment of ligand-recep-
tor interactions [33], it has recently been demonstrated that
energized mitochondria contain two independent spermine
binding sites, S1 and S2, both with monocoordination and
low a⁄nity and high binding capacity, located on the outer
membrane and/or on the external surface of the inner mem-
brane [34]. As proposed in the previous study, binding of
spermine to the S1 site would be competent for the prevention
of the permeability transition and polyamine transport into
the matrix. The S2 site may be involved in the activation of
mitochondrial Ca2 uptake [36] and possibly in other activ-
ities such as the spermine-dependent mitochondrial transport
of some cytosolic enzymes [37,38]. Di¡erent functions for the
two mitochondrial spermine binding sites have also been pro-
posed by other authors [36].
The thermodynamic model analysis of spermine binding in
deenergized mitochondria clearly demonstrates that FCCP
and antimycin A promote a remarkable perturbation of
both binding sites. These deenergizing agents induce a strong
reduction in S1 binding and a strong enhancement in S2 bind-
ing (see Table 1). The very low L1 values, similar to those
calculated in energized condition, demonstrate that the ¢lling
of both sites is not reciprocally in£uenced (Table 1).
The reduced binding capacity of the S1 site in the presence
of FCCP or antimycin A could account for the incomplete or
delayed protective action exhibited by spermine (see Fig. 1,
panels A and B), compared with the total inhibition of the
permeability transition induced in the usual way (see inset in
Fig. 1),. As reported in this ¢gure, 100 WM spermine produced
the maximum extent of inhibition of the permeability transi-
tion (i.e. 90% and 80% inhibition in FCCP and antimycin A
treated samples, respectively). Very probably, at this external
concentration the amounts of spermine bound to site S1 (i.e.
2.6 and 2.1 nmol/mg protein in the presence of FCCP and
antimycin A, respectively; see Table 2) are not su⁄cient to
completely inhibit the permeability transition, given that at
least 3 nmol/mg protein are necessary to obtain complete pro-
tection in energized mitochondria [34]. Furthermore, these
results can also explain the di¡erent protective e¡ects exhib-
ited by spermine in the presence of the two deenergizing
agents. In fact, spermine is less e¡ective when the permeability
transition is induced by antimycin A than in the presence of
FCCP (compare panels A and B in Fig. 1). It is also possible
that, besides decreasing the spermine binding capacity, FCCP
and antimycin A a¡ect the intrinsic properties of the S1 site.
This is supported by the observation that raising the spermine
concentration to 250 WM or higher does not augment its in-
hibition of the permeability transition (i.e. 90% and 80% pro-
tection in the presence of FCCP and antimycin A, respec-
tively, Fig. 1). At these spermine concentrations the S1 site
is saturated with 2.97 nmol/mg protein in the presence of
FCCP and 2.35 nmol/mg protein in the presence of antimycin
A (see Table 2) but this does not translate to better protec-
tion.
The enhancement of spermine binding capacity observed at
the level of the S2 site may somehow be connected to the large
quantities of casein kinase I and casein kinase II enzymes
taken up by mitochondrial membranes under these conditions
(manuscript in preparation). This fact may have important
implications for the enzymes’ regulation during spermine-
pore interactions. Furthermore, this site could be involved
in the release, mediated by the polyamine, of mersalyl-inhib-
ited phosphate carrier in mitochondria deenergized by FCCP
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[39]. The high spermine concentration (1 mM) necessary to re-
activate this transporter supports this hypothesis.
The reported results do not allow us to infer whether the
observed perturbations in spermine binding sites are due to a
direct e¡ect of the deenergizing agents or to membrane de-
polarization or both. We hypothesize that the change in
binding capacity and the decreased binding a⁄nity are due
to membrane depolarization that a¡ects the normal charge
orientation present in the two sites at physiological v8. The
di¡erent spermine binding parameters obtained in the pres-
ence of FCCP and antimycin A could account for the lower
degree of deenergization induced by antimycin A [40]. Instead,
the particular aliquot distributions of spermine and its in-
creased binding a⁄nity at the S2 site induced by antimycin
A could be ascribed to a direct e¡ect of the molecule.
It was suggested that the transition pore plays an important
role in cell physiology and pathophysiology, that is, in intra-
cellular signal transduction [41], in the control of energy wast-
ing [1], in many types of cell injury [42,43] and in apoptosis
[44]. If we assume that the deenergization achieved in the
presence of ruthenium red plus either FCCP or antimycin A
simulates events occurring in vivo when particular conditions,
e.g. anoxia [45], trigger the permeability transition, the re-
ported results support our belief that spermine plays a central
physiological role in modulating this phenomenon.
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